Mental Disorders

T2D Linked to Higher Alzheimer’s Risk

People with type 2 diabetes (T2D) develop Alzheimer’s disease (AD) at a rate of about 4.71 cases per 1,000 person-years, and face a 53% higher AD risk than those without T2D. These findings come from a systematic review and meta-analysis of 40 studies covering more than 27 million data points. The analysis found that incidence was 4.00 per 1,000 person-years in studies using administrative ascertainment, versus 10.24 per 1,000 person-years in those using non-administrative ascertainment. Women had a numerically higher incidence than men (3.62 vs. 2.76 per 1,000 person-years), although adjusted relative risks were similar (1.73 vs. 1.76). Findings were generally consistent across subgroups and robust in sensitivity analyses. Integrating incidence and relative risk estimates clarifies both the absolute and relative burden of AD in T2D, and supports integrating cognitive risk prevention into T2D care. Source: https://link.springer.com/

hyangiu

Recent Posts

Modified Position Management Improved Outcomes in Heart Failure Patients

In a single-center, parallel-group, randomized superiority trial of 150 Chinese hospitalized heart failure patients with…

45 minutes ago

Proteomic Study Identified Novel Ischemic Stroke Risk Factors

A proteomic and genomic investigation combining the ARIC and CHS cohorts has identified 44 proteins…

1 hour ago

ACS Updates Prostate Cancer Screening Guidance

The American Cancer Society (ACS) concludes that the benefits of PSA-based screening for prostate cancer…

4 days ago

Proton Pump Inhibitor Use Linked to Dementia Risk in Older Adults

Proton pump inhibitor (PPI) use was modestly associated with incident dementia in older adults (pooled…

5 days ago

Long-Term Outcomes of Invasive vs Conservative Management in Stable Coronary Disease: Consistent Evidence From Extended Follow-Up Trials

Extended follow-up of three major trials consistently shows that an initial invasive strategy does not…

6 days ago

Antidepressants Differ in Efficacy and Acceptability in Long-Term Treatment of Major Depressive Disorder

Escitalopram, duloxetine, and agomelatine achieved higher sustained response rates than fluoxetine, while escitalopram and duloxetine…

6 days ago

This website uses cookies.